Search…

    Saved Articles

    You have not yet added any article to your bookmarks.

    Browse

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    Baby thrives after receiving personalized gene-editing therapy

    10 hours ago

    One week after he was born, KJ Muldoon was diagnosed with what doctors call a CPS-1 deficiency, essentially meaning he was missing a critical liver enzyme. With doctors believing they only had six months to come up with a solution, KJ became the first patient in the world to receive a custom gene-editing drug in February — and he is thriving after three doses of the therapy. NBC’s Erin McLaughlin reports for TODAY on how this could be a blueprint for future treatment.
    Click here to Read more
    Prev Article
    Olympians share golden rules for pool safety
    Next Article
    Consumer sentiment falls in May as Americans' inflation expectations jump after tariffs

    Related Health Updates:

    Comments (0)

      Leave a Comment